Innate Pharma SA 20-F for FY2025
Innate Pharma SA (IPHA)
20-F
2026-04-01
For: 2025-12-31
View Original
Added on
April 06, 2026
About this 20-F
Innate Pharma SA filed this 20-F on April 1, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 9.01M EUR
- down 55.2% from 20.12M EUR a year earlier
- Net loss
- 49.18M EUR
- compared with a net loss of 49.47M EUR a year earlier
- Diluted EPS
- -0.55 EUR
- compared with -0.61 EUR a year earlier